GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aquarius Surgical Technologies Inc (OTCPK:AQQRF) » Definitions » Net Issuance of Preferred Stock

Aquarius Surgical Technologies (Aquarius Surgical Technologies) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Aquarius Surgical Technologies Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Aquarius Surgical Technologies's net issuance of preferred for the three months ended in Dec. 2023 was $0.00 Mil. The number is 0, which means that Aquarius Surgical Technologies has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Aquarius Surgical Technologies's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.


Aquarius Surgical Technologies Net Issuance of Preferred Stock Historical Data

The historical data trend for Aquarius Surgical Technologies's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aquarius Surgical Technologies Net Issuance of Preferred Stock Chart

Aquarius Surgical Technologies Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Net Issuance of Preferred Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Aquarius Surgical Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Issuance of Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Aquarius Surgical Technologies Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aquarius Surgical Technologies Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Aquarius Surgical Technologies's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Aquarius Surgical Technologies (Aquarius Surgical Technologies) Business Description

Traded in Other Exchanges
Address
89 Scollard Street, Toronto, ON, CAN, M5R 1G4
Aquarius Surgical Technologies Inc is engaged in the development, sale, distribution, marketing, and exploitation of laser-driven technologies for use in surgical environments, principally in the field of urology. The company derives revenue from the sale of medical devices and fiber-optic delivery devices. Geographically, it has a presence in Canada, the United States, and the Dominican Republic.